CaroGoLoop Profile Banner
CaroGo Profile
CaroGo

@CaroGoLoop

Followers
486
Following
10K
Media
2K
Statuses
8K

#Looperin #Typ1 #WeAreNotWaiting #AAPS #YDMV #Dedocvoice organisiere regelmäßige #LOOPERTREFFEN im Großraum Köln. Loop seit 2017, dankbar dafür! 💙 carogoloop

https://luckyloop.koeln
Joined March 2020
Don't wanna be here? Send us removal request.
@CaroGoLoop
CaroGo
2 years
Hier ist das Video Statement #insulinconsensus Wir, und vermutlich ALLE möchten, dass sich die Situation in Krisengebieten ändert! Was kann man tun? Als Erstes auf jeden Fall die Stimme erheben! https://t.co/dwhbTlaH8S SEI DABEI! Teile deine Stimme! https://t.co/gEWhOlyLsP
1
2
3
@SpareARose
SpareARose
2 days
Final day of #SpareARose🌹 With over 60 individual donors, this community showed up with generosity and heart. While a corporate match wasn’t possible this year, the impact of collective giving is real & we’re deeply grateful Thank you for standing w/us https://t.co/BOtIRJxWz2
0
4
7
@SpareARose
SpareARose
3 days
Day 27 of #SpareARose 🌹 One day to go. One last chance to spare a rose and help move insulin where it’s needed most. Join us today. 🔗 [ https://t.co/BOtIRJxWz2]
0
4
5
@SpareARose
SpareARose
5 days
Day 25 of #SpareARose 🌹 This is what collective action looks like — people choosing to care, to act, to change lives. A few days left. Still time to join. 🔗 [ https://t.co/BOtIRJxWz2]
0
5
6
@SpareARose
SpareARose
7 days
Day 23 of #SpareARose 🌹 Quiet days don’t stop real movements. There’s still time. Still need. Still impact to make. Join us. 🔗 [ https://t.co/BOtIRJxWz2]
0
3
4
@SpareARose
SpareARose
10 days
Day 20 of #SpareARose 🌹 This isn’t about discovering a campaign — it’s about choosing to care. February is moving fast. The need isn’t waiting. Make the choice. Join us. 🔗 [ https://t.co/BOtIRJxWz2]
0
3
3
@Prof_AJ_Jenkins
Prof AJ Jenkins
27 days
I am on the volunteer Board of Insulin For Life. Please help IFL continue their great work in over 30 disadvantaged countries + during disasters providing insulin + related supplies to those in need. Please donate funds via https://t.co/R7OEwVYWKl + share this message widely.
0
2
5
@BT1DUK
Breakthrough T1D UK
1 month
New opportunity to participate in type 1 diabetes (T1D) research. Researchers at the University of Warwick are creating a mobile app designed to support the mental health of adolescents (aged 11- to 17-years old) living with type 1 diabetes (T1D). During this study, adolescents
1
6
5
@CaroGoLoop
CaroGo
1 month
Meinen Bericht über den GS3 CGM-Sensor von @SibionicsCGM findet ihr hier: https://t.co/wOqKBvJHv8 #cgm #typ1 #Diabetes #typ2
0
0
0
@nerdabetic
Kamil
1 month
My diabetes tech “budget” mostly goes to: • bolusing for big meals • training at the gym • checking trends when I need them Alarms didn’t make the cut — and that’s intentional. Watch my new video: The Hidden Cost of Diabetes Tech: Your Attention https://t.co/CoM7uGUfzM
1
3
8
@nerdabetic
Kamil
1 month
Thanks so much @flippper1 👏🏻 Emotional cost of diabetes tech is something I’ve been to highlight in this piece Video here: The Hidden Cost of Diabetes Tech: Your Attention https://t.co/CoM7uGUfzM
@flippper1
Flipper
1 month
Great video on the emotional cost we choose to pay for living with diabetes from @nerdabetic. Definitely worth a 👀!!
0
1
5
@BreakthroughT1D
Breakthrough T1D
2 months
We've updated our CGM resources to help you navigate using a CGM as part of your T1D care--including customer support information, what to do when your symptoms don't match your CGM reading, and more. As always, we'll continue listening and responding to what the T1D community
0
3
5
@dedocORG
#dedoc°
2 months
🌍 Let’s end diabetes stigma—together. The Global Summit to End Diabetes Stigma brings lived experience, advocacy & research into action. 📍 Jaipur, India | 🗓 Mar 28–29, 2026 ✈️ Travel grants available for attendees via #dedoc° Apply here: https://t.co/McGZfUsjEX
0
7
8
@parthaskar
Partha S Kar 🇮🇳🇬🇧🏏🎥
2 months
Big news from Europe in the world of #T1Diabetes @EU_Commission Approval for use of 'Teplizumab' to delay onset of #T1D As regards #NHS - @NICEComms due to make their call in April 2026 ( https://t.co/SwZZWL5rcG) Will the UK follow with approvals- and importantly- much more
2
6
20
@nerdabetic
Kamil
2 months
Huge news for sure! European approval of Teplizumab which delays the onset of type 1 diabetes. In my type 1 diabetes screening documentary, I’ve spoken with several experts and users about screening and how Teplizumab is being used globally. Watch here: https://t.co/2HcMYxQyJZ
@parthaskar
Partha S Kar 🇮🇳🇬🇧🏏🎥
2 months
Big news from Europe in the world of #T1Diabetes @EU_Commission Approval for use of 'Teplizumab' to delay onset of #T1D As regards #NHS - @NICEComms due to make their call in April 2026 ( https://t.co/SwZZWL5rcG) Will the UK follow with approvals- and importantly- much more
0
4
9
@tinodzikiti
Diabetic_Mogul
2 months
🎙️ OUT NOW New Global Diabetes Podcast episode with @DrAAddala (Stanford). Pediatric T1D. Equity gaps. Provider bias. Access to technology. Real talk. Real urgency. 🎧 Watch now on YouTube: https://t.co/TLiDvhrDMd #T1D #HealthEquity #GlobalDiabetes #PediatricDiabetes
0
2
4
@tinodzikiti
Diabetic_Mogul
2 months
🎙️Season’s greetings, we sit down w/@DrAAddala to confront the hard truths in pediatric T1D care — widening inequities, provider bias, tech access interruptions, and why advocacy in medicine is non-negotiable This isn’t comfort listening! It’s a call to action! #GlobalDiabetes
0
1
5
@dedocORG
#dedoc°
2 months
Watch out, Barcelona here we come ✈️🔥
 Applications for ATTD are officially open! 📍 Barcelona
 📅 March 11–14, 2026
 ⏰ Apply by January 2 🔗 https://t.co/k0DbAB66aY Don’t miss your chance, apply now 💥 #conference #Barcelona #networkingevent #diabetes #community
0
8
10
@Moodwife
Dawnie
3 months
Nice to see this, and delighted to see it giving a nod to one of my works 😉 https://t.co/ZNod3144RG
2
6
15
@t1international
T1International
3 months
Dexcom is ending G6 production, while G7 safety concerns have led to health risks & deaths. Our #insulin4all community is speaking out. Everyone with diabetes deserves safe, effective tools, and a market free from monopolies that restrict access. https://t.co/ThvmScMFeY
1
3
7